The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Gilead Sciences; Janssen-Cilag; Roche; Takeda
Research Funding - Gilead Sciences (Inst); Janssen-Cilag (Inst); Roche (Inst); Takeda
Travel, Accommodations, Expenses - Gilead Sciences; Roche; Takeda
 
Research Funding - Celltrion; Dong-A Socio; Johnson & Johnson; Kyowa Hakko Kirin; Mundipharma; Pfizer; Roche; Takeda
Response to A+CHP by CD30 expression in the ECHELON-2 trial.
 
Ranjana H. Advani
Consulting or Advisory Role - AstraZeneca; Autolus; Bayer; Bristol-Myers Squibb; Cell Medica; Genentech/Roche; Gilead Sciences; Pharmacyclics; Seagen; Takeda
Research Funding - Agensys (Inst); Celgene (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Kura Oncology (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Regeneron (Inst); Seagen (Inst)
 
Steven M. Horwitz
Consulting or Advisory Role - ADC Therapeutics; Celgene; Corvus Pharmaceuticals; Innate Pharma; Kyowa Hakko Kirin; Millennium; miRagen; Portola Pharmaceuticals; Seagen; Takeda; Verastem
Research Funding - ADC Therapeutics; Aileron Therapeutics; Celgene; Forty Seven; Kyowa Hakko Kirin; Seagen; Takeda; Verastem
 
Swaminathan Padmanabhan Iyer
Research Funding - Arog (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Incyte (Inst); Novartis (Inst); Takeda (Inst)
 
Nancy L. Bartlett
Consulting or Advisory Role - ADC Therapeutics; Pfizer; Seagen
Research Funding - Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech (Inst); Gilead Sciences (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Seagen (Inst)
 
Won Seog Kim
No Relationships to Disclose
 
Herve Tilly
Honoraria - Bristol-Myers Squibb; SERVIER
Consulting or Advisory Role - Janssen; Karyopharm Therapeutics; Roche
Travel, Accommodations, Expenses - Roche
 
David Belada
No Relationships to Disclose
 
Tatyana Feldman
Honoraria - Abbvie; Bayer; Bristol-Myers Squibb; Kite, a Gilead company; Pharmacyclics/Janssen; Seagen; Takeda
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Seagen
Speakers' Bureau - Abbvie; Celgene; Janssen; Kite, a Gilead company; Pharmacyclics; Seagen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Cell Medica (Inst); Eisai (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Pfizer (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); Trillium Therapeutics (Inst); Viracta Therapeutics (Inst); Viracta Therapeutics (Inst)
Travel, Accommodations, Expenses - Abbvie; Kite, a Gilead company; Pharmacyclics; Seagen; Takeda
 
Árpád Illés
Consulting or Advisory Role - Celgene; Janssen; Novartis; Roche; Takeda
Research Funding - Seagen (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche; Takeda
 
Eric D. Jacobsen
Consulting or Advisory Role - Janssen; Merck; Seagen
Research Funding - Celgene
Travel, Accommodations, Expenses - Merck
 
Andreas Huettmann
Honoraria - Takeda
Consulting or Advisory Role - Gilead Sciences; Pfizer
Travel, Accommodations, Expenses - Celgene; Roche
 
Pier Luigi Zinzani
Honoraria - Bristol-Myers Squibb; Gilead Sciences; Janssen; MSD; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Janssen; MSD; SERVIER
Speakers' Bureau - Bristol-Myers Squibb; Gilead Sciences; Janssen; MSD; SERVIER
 
Owen A. O'Connor
Honoraria - Millennium; Mundipharma; Novartis; Seagen
Consulting or Advisory Role - Allos Therapeutics; Millennium; Mundipharma; Novartis; Seagen; Spectrum Pharmaceuticals
Research Funding - Acetylon Pharmaceuticals; Celgene; Millennium; Roche; Seagen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Acetylon Pharmaceuticals; Millennium; Mundipharma; Seagen; Spectrum Pharmaceuticals
 
William L. Trepicchio
Employment - Takeda
 
Harry H. Miao
Stock and Other Ownership Interests - Takeda; Takeda
 
Shangbang Rao
Employment - Bristol-Myers Squibb; Seagen
Stock and Other Ownership Interests - Seagen
 
Matthew Onsum
Employment - Seagen; Seagen
Stock and Other Ownership Interests - Seagen
 
Thomas John Manley
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Tim Illidge
Consulting or Advisory Role - Millennium
Speakers' Bureau - Millennium